A recent McKinsey analysis shows that first-time launches are projected to outnumber those from established companies by nearly two to one. As companies seek to move from the clinic to market, understanding how to successfully commercialize products, create investor value, and serve patient needs remain critical considerations. Leadership teams must navigate regulators, negotiate with payers, develop marketing and sales strategies, and have the talent to execute on these priorities. There is no one size fits all approach given different patient populations for different indications and disease types. You will hear from experienced executives on how to navigate challenges and prepare for successful product launches. ​